Comparative evaluation of neuroendocrine dysfunction in children with craniopharyngiomas before and after mass effects are removed
-
Ying Guo
Abstract
Objective
To compare the effects of mass effects in situ (MEIS) and after neurosurgery (ANS) on neuroendocrine function in children with craniopharyngioma.
Methods
We retrospectively investigated 185 cases of children with craniopharyngioma who underwent neurosurgical treatment at the Beijing Tiantan Hospital from 2011 to 2016. The neuroendocrine function of patients was compared before and after tumor removal.
Results
Compared with the MEIS, the incidence of growth hormone insulin-like growth factor 1 axis dysfunction (47.03% vs. 57.30%), pituitary-thyroid axis dysfunction (20.00% vs. 50.27%), pituitary-adrenal axis dysfunction (18.38% vs. 43.78%) and diabetes insipidus (26.49% vs. 44.86%) was significantly increased in the ANS status. The incidence of hyperprolactinemia significantly decreased from 28.11% in the MEIS status to 20.54% in the ANS status. Compared with the MEIS group, changes in appetite, development of diabetes insipidus, body temperature dysregulation, sleeping disorders, personality abnormalities and cognitive abnormalities were more frequent after ANS, yet no statistically significant differences were found.
Conclusions
Endocrine dysfunction is common in children with craniopharyngioma. Both MEIS and ANS can be harmful to neuroendocrine function, and neurosurgical treatment may increase the level of neuroendocrine dysfunction.
Acknowledgments
None declared.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was funded by the Characteristic Project on Capital Clinical Research, the Beijing Municipal Science and Technology Committee (No. Z181100001718122), and the Research Special Fund for Public Welfare Industry of Health (No. 201402008).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Hage M, Lombes M, Chanson P. Craniopharyngiomas: progress in pathogenesis and therapeutics. Ann Endocrinol (Paris) 2014;75(Suppl 1):S46–54.10.1016/S0003-4266(14)70026-5Suche in Google Scholar
2. Steinbok P. Craniopharyngioma in children: long-term outcomes. Neurol Med Chir (Tokyo) 2015;55:722–6.10.2176/nmc.ra.2015-0099Suche in Google Scholar PubMed PubMed Central
3. Wijnen M, van den Heuvel-Eibrink MM, Janssen J, Catsman-Berrevoets CE, Michiels EM, et al. Very long-term sequelae of craniopharyngioma. Eur J Endocrinol 2017;176:755–67.10.1530/EJE-17-0044Suche in Google Scholar PubMed
4. Li GM, Sun XJ, Shao P. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas. Chin Med J (Engl) 2008;11:2077–82.10.1097/00029330-200810020-00025Suche in Google Scholar
5. Daubenbuchel AM, Muller HL. Neuroendocrine disorders in pediatric craniopharyngioma patients. J Clin Med 2015;4:389–413.10.3390/jcm4030389Suche in Google Scholar PubMed PubMed Central
6. Capital Institute of P, Coordinating Study Group of Nine Cities on the Physical G, Development of C. Growth standardized values and curves based on weight for length/height, body mass index for Chinese children under 7 years of age. Zhonghua Er Ke Za Zhi 2009;47:281–5. (In Chinese).Suche in Google Scholar
7. Group of China Obesity Task F. Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents. Zhonghua Liu Xing Bing Xue Za Zhi 2004;25:97–102. (In Chinese).Suche in Google Scholar
8. Muller HL, Muller-Stover S, Gebhardt U, Kolb R, Sorensen N, et al. Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 2006;19(Suppl 1):423–9.10.1055/s-2006-954715Suche in Google Scholar
9. Verrillo E, Bizzarri C, Cappa M, Bruni O, Pavone M, et al. Sleep characteristics in children with growth hormone deficiency. Neuroendocrinology 2011;94:66–74.10.1159/000326818Suche in Google Scholar PubMed
10. Thigpen JC, Pearson M, Robinson KE, Andreotti C, Dunbar JP, et al. Presurgical assessment of cognitive function in pediatric brain tumor patients: feasibility and initial findings. Neurooncol Pract 2016;3:261–7.10.1093/nop/npv066Suche in Google Scholar PubMed PubMed Central
11. Sato T. The Eysenck Personality Questionnaire Brief Version: factor structure and reliability. J Psychol 2005;139:545–52.10.3200/JRLP.139.6.545-552Suche in Google Scholar PubMed
12. Di Iorgi N, Allegri AE, Napoli F, Calcagno A, Calandra E, et al. Central diabetes insipidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J Clin Endocrinol Metab 2014;99:1264–72.10.1210/jc.2013-3724Suche in Google Scholar PubMed
13. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, et al. A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 2010;182:246–51.10.1164/rccm.200911-1738OCSuche in Google Scholar PubMed PubMed Central
14. Aslan IR, Cheung CC. Early and late endocrine effects in pediatric central nervous system diseases. J Pediatr Rehabil Med 2014;7:281–94.10.3233/PRM-140299Suche in Google Scholar PubMed
15. Scherdel P, Reynaud R, Pietrement C, Salaun JF, Bellaiche M, et al. Priority target conditions for algorithms for monitoring children’s growth: interdisciplinary consensus. PLoS One 2017;12:e0176464.10.1371/journal.pone.0176464Suche in Google Scholar PubMed PubMed Central
16. Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0–18 years. Zhonghua Er Ke Za Zhi 2009;47:487–92. (In Chinese).Suche in Google Scholar
17. Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, et al. Incidence of craniopharyngioma in Denmark (n=189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 2011;104:755–63.10.1007/s11060-011-0540-6Suche in Google Scholar PubMed
18. Erfurth EM. Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab 2015;28:19–26.10.1515/jpem-2014-0419Suche in Google Scholar PubMed
19. Daubenbüchel AM, Müller HL. Neuroendocrine disorders in pediatric craniopharyngioma patients. J Clin Med 2015;4: 389–413.10.3390/jcm4030389Suche in Google Scholar PubMed PubMed Central
20. Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, et al. A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol 2014;50:4–10.10.1016/j.pediatrneurol.2013.09.003Suche in Google Scholar PubMed
21. Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, et al. Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 2013;98:3253–62.10.1210/jc.2013-2000Suche in Google Scholar PubMed
22. Shohdy KS, Rashad W. Endocrine disorders developing after surgical intervention of craniopharyngioma in children. Pediatr Endocrinol Rev 2017;14:298–301.Suche in Google Scholar
23. Lopez-Serna R, Gomez-Amador JL, Barges-Coll J, Nathal-Vera E, Revuelta-Gutierrez R, et al. Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience. Arch Med Res 2012;43:347–55.10.1016/j.arcmed.2012.06.009Suche in Google Scholar PubMed
24. Khan RB, Merchant TE, Boop FA, Sanford RA, Ledet D, et al. Headaches in children with craniopharyngioma. J Child Neurol 2013;28:1622–5.10.1177/0883073812464817Suche in Google Scholar PubMed PubMed Central
25. Liang D, Guo Y. Preliminary evaluation for the reserved function of growth hormone in pituitary of patients with craniopharyngioma after surgery. Zhonghua Lin Chuang Yi Shi Za Zhi 2013;7:71–4. (In Chinese).Suche in Google Scholar
26. Alotaibi NM, Noormohamed N, Cote DJ, Alharthi S, Doucette J, et al. Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients: a meta-analysis. World Neurosurg 2018;109:487–96 e1.10.1016/j.wneu.2017.09.164Suche in Google Scholar PubMed PubMed Central
27. Gataullina S, Delonlay P, Lemaire E, Boddaert N, Bulteau C, et al. Seizures and epilepsy in hypoglycaemia caused by inborn errors of metabolism. Dev Med Child Neurol 2015;57:194–9.10.1111/dmcn.12574Suche in Google Scholar PubMed
28. Olsson DS, Buchfelder M, Wiendieck K, Kremenevskaja N, Bengtsson BA, et al. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up. Eur J Endocrinol 2012;166:1061–8.10.1530/EJE-12-0077Suche in Google Scholar PubMed
29. Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab 2015;100:467–74.10.1210/jc.2014-3525Suche in Google Scholar PubMed
30. Elliott RE, Sands SA, Strom RG, Wisoff JH. Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurg Focus 2010;28:E2.10.3171/2010.2.FOCUS09304Suche in Google Scholar PubMed
31. Chakrabarti I, Amar AP, Couldwell W, Weiss MH. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma. J Neurosurg 2005;102:650–7.10.3171/jns.2005.102.4.0650Suche in Google Scholar PubMed
32. Jiang LY, Xu J, Zhong LY. A clinical analysis of 183 patients with craniopharyngioma. Zhonghua Yi Shi Jin Xiu Za Zhi 2008;31:18–21. (In Chinese).Suche in Google Scholar
33. Guo Y, Zhong LY. Clinical research on neuroendocrine dysfunction and grading of neuroendocrine function in children with craniopharyngioma. Zhonghua Yi Shi Jin Xiu Za Zhi 2016;38:674–9. (In Chinese).Suche in Google Scholar
34. Memmesheimer RM, Lange K, Dolle M, Heger S, Mueller I. Psychological well-being and independent living of young adults with childhood-onset craniopharyngioma. Dev Med Child Neurol 2017;59:829–36.10.1111/dmcn.13444Suche in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Mini Review
- Clinical, biochemical, and molecular spectrum of short/branched-chain acyl-CoA dehydrogenase deficiency: two new cases and review of literature
- Original Articles
- Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus
- Frequency, clinical characteristics, biochemical findings and outcomes of DKA at the onset of type-1 DM in young children and adolescents living in a developing country – an experience from a pediatric emergency department
- Hepatopathies in children and adolescents with type 1 diabetes
- Comparative evaluation of neuroendocrine dysfunction in children with craniopharyngiomas before and after mass effects are removed
- Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence
- Socioeconomic status of the population – a prime determinant in evaluating iodine nutritional status even in a post salt iodization scenario
- Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience
- Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients
- Maternal factors associated with neonatal vitamin D deficiency
- IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children
- One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty
- Letter to the Editor
- Prediabetes in children and adolescents in the United States: prevalence estimates and comorbidities – a population analysis
- Case Reports
- Severe in utero under-virilization in a 46,XY patient with Silver-Russell syndrome with 11p15 loss of methylation
- Carney complex due to a novel pathogenic variant in the PRKAR1A gene – a case report
- Challenging diagnosis of thyroid hormone resistance initially as Hashimoto’s thyroiditis
Artikel in diesem Heft
- Frontmatter
- Mini Review
- Clinical, biochemical, and molecular spectrum of short/branched-chain acyl-CoA dehydrogenase deficiency: two new cases and review of literature
- Original Articles
- Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus
- Frequency, clinical characteristics, biochemical findings and outcomes of DKA at the onset of type-1 DM in young children and adolescents living in a developing country – an experience from a pediatric emergency department
- Hepatopathies in children and adolescents with type 1 diabetes
- Comparative evaluation of neuroendocrine dysfunction in children with craniopharyngiomas before and after mass effects are removed
- Functional and endocrine-metabolic oligomenorrhea: proposal of a new diagnostic assessment tool for differential diagnosis in adolescence
- Socioeconomic status of the population – a prime determinant in evaluating iodine nutritional status even in a post salt iodization scenario
- Long-term outcome of hyperthyroidism diagnosed in childhood and adolescence: a single-centre experience
- Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients
- Maternal factors associated with neonatal vitamin D deficiency
- IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children
- One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty
- Letter to the Editor
- Prediabetes in children and adolescents in the United States: prevalence estimates and comorbidities – a population analysis
- Case Reports
- Severe in utero under-virilization in a 46,XY patient with Silver-Russell syndrome with 11p15 loss of methylation
- Carney complex due to a novel pathogenic variant in the PRKAR1A gene – a case report
- Challenging diagnosis of thyroid hormone resistance initially as Hashimoto’s thyroiditis
